-
Latest News
- Dysregulated provision of oxidisable substrates to the mitochondria in ME/CFS lymphoblasts
- Sex-based differences in plasma autoantibodies to CNS proteins in Gulf War veterans versus healthy & symptomatic controls
- Sick of the sick role: narratives of what ‘recovery’ means to people with CFS/ME
- Plasma proteomics publication shows disrupted cell-to-cell signaling in ME/CFS
- Open‐label study with the monoamine stabilizer (‐)‐OSU6162 [drug] in ME/CFS
Archives
Tag Archives: Jon D Kaiser
KPAX002 as a treatment for ME/CFS – disappointing trial results
Research abstract: KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a prospective, randomized trial, by Jose G Montoya, Jill N Anderson, Danya L Adolphs, Lucinda Bateman, Nancy Klimas, Susan M Levine, Donn W Garvert, Jon D Kaiser … Continue reading →
Posted in News
|
Tagged Danya L Adolphs, Donn W Garvert, Dr Jose Montoya, Dr Lucinda bateman, Dr Nancy Klimas, Dr Susan Levine, hypometabolic disorder, Jill Anderson, Jon D Kaiser, KPax Synergy trial, KPAX002, methylphenidate hydrochloride, mitochondrial dysfunction
|
Comments Off on KPAX002 as a treatment for ME/CFS – disappointing trial results
